si-HNF1A-AS1 combined with miR-22 mimics group was strongly reduced the malignant phenotype of GBM cells, while miR-22 inhibitors reversed the suppression of HNF1A-AS1 attenuated in GBM cells (Fig. 7A–D). Here, HNF1A is linked to glioblastoma.